Gastrointestinal cancer refers to malignant conditions of the gastrointestinal (GI) tract, including the esophagus, stomach, liver, biliary system, pancreas, bowels, and anus.
CA 19-9
a useful GI tumor marker and it seems to be
better than CEA in some pathologic situations.
PMID: 3468674
CA50 and CA242
are valuable markers in the diagnosis of
digestive tract tumor.
PMID: 11367693
CDX-2
a new
marker for adenocarcinoma of gastrointestinal origin.
PMID: 15090846
GST-pi (glutathione-S-transferase-pi)
serum GST-pi assays provide a sensitive and
reliable marker for gastrointestinal malignancies.
PMID: 2910437
Guanylyl
cyclase C
a
marker of intestinal metaplasia, dysplasia, and adenocarcinoma
of the gastrointestinal tract.
PMID: 15754294
PHI (phosphohexose isomerase)
serum PHI can be a useful indicator in the
preventive checkup of gastrointestinal and renal cancer in
medical practice.
PMID: 2207761
TPEF
a tumor marker that could be useful in the
follow-up of gastrointestinal cancer patients or the screening
of individuals at risk of developing gastrointestinal neoplasms.
PMID: 15068392
Tumor M2-PK
with the fuzzy logic method and a tumor
marker panel (including Tumor M2-PK), a new diagnostic tool for
the detection of gastro-intestinal cancers is available.
PMID: 16033052
might be a valuable marker in
gastrointestinal cancer.
PMID: 11326648
A combination of Tumor M2-PK with the
appropriate first choice-marker (e.g. CEA + Tumor M2-PK for
colorectal cancer) resulted in a remarkable increase in the
sensitivities.
PMID: 11326647